Navigation Links
Pharmion's Oral Azacitidine Granted Fast Track Status for Myelodysplastic Syndromes
Date:8/29/2007

BOULDER, Colo., Aug. 29 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for oral Azacitidine in the treatment of Myelodysplastic Syndromes (MDS).

Fast Track programs are designed to facilitate the development and expedite the review of new drugs that are intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast Track emphasizes the critical nature of close, early communication between the FDA and sponsors. The benefits of Fast Track include scheduled meetings to seek FDA input into development plans, and the option of submitting a New Drug Application in sections rather than all components simultaneously. These meetings can help the FDA and sponsors reach early agreement on design of the clinical efficacy studies that will be needed to support approval.

The FDA stated that Fast Track designation was granted for oral Azacitidine for MDS because Azacitidine is approved to treat all subtypes of MDS, and because it will potentially provide a safer, more comfortable, more convenient and more efficient route of administration of Azacitidine.

"We are extremely enthusiastic about working closely with Pharmion to drive the development of oral Azacitidine," said Dr. Hagop Kantarjian, chair of the department of leukemia at the University of Texas M.D. Anderson Cancer Center. "Vidaza has now demonstrated a unique and profound survival benefit in higher-risk MDS, and we think oral Azacitidine may provide significant benefit in treating lower risk forms of MDS as well. We are delighted that the FDA shares our view that its developme
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Mirus granted European patent for gene therapy
2. Platypus granted new liquid crystal patent
3. WARF Granted New Antibiotics Patent
4. Identity theft start up has fast-track growth plans
5. In pursuit of capital, be sure to track your private offering
6. Jellyfish partners for sales tracking technology
7. Medical College team creates website for tracking flu
8. Johnson Controls deals for asset-tracking software
9. RFID system aids hospital in tracking assets
10. State tracks more angel investment, at least $19M last year
11. On track with the FDA -- But what about your coverage and reimbursement strategy?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... (PRWEB) May 16, 2013 Cambridge Healthtech ... from August 19-23, 2013 at the Renaissance Waterfront Hotel ... Summit provide a close-up look at the current strategies ... ensuring bottom-line quality. Leaders in the field will ... to produce biopharmaceuticals with greater specificity and efficiency. , ...
(Date:5/16/2013)... , May 16, 2013  HealthSparq, a ... of the nation,s largest regional health plans, will ... Health Insurance Plans (AHIP) Institute 2013 conference on ... survey results showing how health insurance companies across ... the consumer and marketplace demands for increased healthcare ...
(Date:5/16/2013)... HAYWARD, Calif. , May 16, 2013 ... University, Beijing , and the ... www.magceutics.com ) have demonstrated a novel therapy for reversing ... brain magnesium levels, they find significant cognitive improvement in ... to demonstrate a mechanism for reversing cognitive decline for ...
(Date:5/16/2013)... May 16, 2013 On average, developing ... over one billion dollars. Despite this investment, less than ... this high, is your clinical trial design optimally structured ... best outcomes? , Dr. Frederic Sax, Global Head of ... the use of data, information and technology in upfront ...
Breaking Biology Technology:The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... When it comes to the health of their,children and even ... possible about health and medicine. With the many different,medicines out there, ... is taking,what and the dangers of drug reactions, interactions and side ... ) , In fact, ...
... CHARENTON-LE-PONT, France, December 3 On,November 28, Essilor cancelled ... offset the dilutive impact of Oceane bond conversions and,the ... These latest cancellations concerned shares acquired under ... of Directors on July,15, 2008 to offset the dilutive ...
... 2 Decision Biomarkers Inc, a leading,developer of ... today announced the formation of a Scientific Advisory ... the,forefront of biomarker and clinical research. The Scientific ... -- Daniel W. Chan, Ph.D., Director of ...
Cached Biology Technology:Family Medicine Cabinet: Free, New On-Line Tool Helps Track Your Medication Safety 2Decision Biomarkers Inc Announces Formation of Scientific Advisory Board 2
(Date:5/18/2013)... Bethesda, MD (May 19, 2013) The AGA Research ... Augustyn and Damian Augustyn Award in Digestive Cancer, which ... School of Medicine at the University of Pennsylvania, Philadelphia, ... Zeb1 in pancreas development, regeneration and cancer progression. , ... award in honor of two distinguished clinicians and AGA ...
(Date:5/18/2013)... presented today at Digestive Disease Week (DDW) explores new ... impact of coffee on autoimmune disease and palliative care ... has been associated with reduced risk of fibrosis, a ... of java each month also correlate with lower risk ... Mayo Clinic, Rochester, MN, linked coffee consumption with reduced ...
(Date:5/18/2013)... Research presented at Digestive Disease Week (DDW) explores ... and lifestyle. , Individuals suffering from Crohn,s ... fatigue and poor quality of life. These symptoms ... A randomized, double blind, placebo-controlled study found for ... to significant relief of these symptoms. , ...
Breaking Biology News(10 mins):AGA Research Foundation grant furthers digestive cancer research 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Research examines new methods for managing digestive health 2Research examines new methods for managing digestive health 3
... Proof of Concept Center to drive technology commercialization, ... been awarded a $1.1 million grant from the ... Tech "LA_i6" Proof of Concept Center to support ... innovations into markets throughout the region and the ...
... 30, 2011 -- Molecular motion in proteins comes ... by researchers at the Department of Energy,s Oak ... in research reported in Physical Review Letters. ... Chairs Jeremy Smith and Alexei Sokolov, combined high-performance ...
... to be removed from the federal endangered species list, the ... natural resources for the public good should guide state ... issue of the journal Science , the researchers note ... including wildlife, have no owners and therefore belong to all ...
Cached Biology News:Louisiana Tech University receives $1.1 million EDA grant to support 'green' innovations 2Louisiana Tech University receives $1.1 million EDA grant to support 'green' innovations 3High-performance simulation, neutrons uncover 3 classes of protein motion 2Researchers: Apply public trust doctrine to 'rescue' wildlife from politics 2Researchers: Apply public trust doctrine to 'rescue' wildlife from politics 3Researchers: Apply public trust doctrine to 'rescue' wildlife from politics 4
Screening assay to detect the Listeria monocytogenes in food samples by,DNA amplification and molecular hybridization on a microtiter plate....
Multi-enzyme complex containing a wide range of carbohydrases, including arabanase, cellulase,b-glucanase, hemi-cellulase and xylanase Patent/trademark/license (electronic): A product of Novozyme Cor...
... Systems provide rapid, precise localization of ... frozen or paraffin-embedded tissue, cytospins and ... facilitate double or triple labeleing experiments, ... with primary antibodies of different animal ...
Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA (blue), proteins (red) and acid polysaccharides Assay: ~ 95 % Suitab tst: differential staining of nucleic acids and prote...
Biology Products: